Mark A. Berman, Chief Medical Officer at Better Therapeutics, Inc. (BTTX), bought 54,802 shares at $0.73 ($40K) on 2023-07-27, disclosed to the SEC on 2023-07-31.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Something here stands out, but not much.